A revolution is coming in the U.S. generics marketplace, one that has the potential to transform savvy organizations into engines of growth, and to end the decades-long “race to the bottom” that for ...
Indian drugmaker Dr Reddy's Laboratories is likely to launch its generic semaglutide injection in the country in March under the brand name Obeda, according to two people familiar with the matter as ...
For months, President Donald Trump and his aides touted efforts to lower prescription drug prices for Americans. Now consumers can check prices at the recently launched website TrumpRx.gov. "This is a ...
ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. ProPublica on Friday published never-before-released data ...
WASHINGTON--(BUSINESS WIRE)--Tom Neely, chairman of Oxford Pharmaceuticals, testified Wednesday before the U.S. Senate Special Committee on Aging, urging Congress to recognize generic pharmaceuticals ...
The generic product is now available nationwide in strengths of 0.3mg, 0.45mg, 0.625mg, 0.9mg, and 1.25mg. The Food and Drug Administration (FDA) has approved the first generic version of Premarin ® ...
Patients in the U.S. now have access to the first generic GLP-1 treatment approved for weight loss as Teva has launched its copycat of Novo Nordisk’s injected Saxenda (liraglutide). The compound, ...
Aug 28 (Reuters) - The U.S. Food and Drug Administration has approved Teva Pharmaceuticals' (TEVA.TA), opens new tab cheaper generic version of Novo Nordisk's (NOVOb.CO), opens new tab older ...
July 16 (Reuters) - A U.S. federal judge rejected Swiss drugmaker Novartis' (NOVN.S), opens new tab request for a preliminary injunction to stop MSN Pharmaceuticals from selling a generic version of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results